Can-Fite BioPharma Ltd. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MORGAN STANLEY | 02/14/2023 | 304,675 | $186,766 | -4.84% | 1.12% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 32,739 | $20,069 | -44.86% | 0.12% |
FIFTH THIRD BANCORP | 01/25/2023 | 30,000 | $18,390 | 0.00% | 0.11% |
TWO SIGMA SECURITIES, LLC | 02/14/2023 | 26,985 | $16,542 | 85.16% | 0.10% |
STIFEL FINANCIAL CORP | 02/13/2023 | 12,000 | $7,357 | 0.00% | 0.04% |
UBS GROUP AG | 02/08/2023 | 8,712 | $5,314 | -49.82% | 0.03% |
NATIONAL BANK OF CANADA /FI/ | 01/24/2023 | 6,000 | $3,666 | 0.00% | 0.02% |
CITIGROUP INC | 02/09/2023 | 5,535 | $3,393 | 0.00% | 0.02% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/15/2024 | 533 | $327 | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2023 | 400 | $245 | 100.00% | 0.00% |
TD WATERHOUSE CANADA INC. | 11/13/2023 | 203 | $164 | 0.00% | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 01/30/2023 | 0 | $0 | 0.00% | 0.00% |
VIRTU FINANCIAL LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
Can-Fite BioPharma Ltd.institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of Can-Fite BioPharma Ltd.. The most heavily invested institutionals were:
American Portfolios Advisors: 1,100
1.57% of Can-Fite BioPharma Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 1,100 shares in the last 24 months. This purchase volume represents approximately $1,705 in transactions.